Marcos Da Silva

Marcos Da Silva

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
EGElisa Gouvea Gutman
Elisa Gouvea Gutman
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JRJéssica Vasques Raposo-Vedovi
Jéssica Vasques Raposo-Vedovi
ASAndreza Salvio Lemos Salvio
Andreza Salvio Lemos Salvio
LDLarissa Araujo Duarte
Larissa Araujo Duarte
SASoniza Vieira Alves-Leon
Soniza Vieira Alves-Leon
SARS-CoV-2 can trigger autoimmune central nervous system (CNS) diseases in genetically susceptible individuals, a mechanism poorly understood. Molecular mimicry (MM) has been identified in other viral diseases as potential triggers of autoimmune CNS events. This study investigated if MM is the process through which SARS-CoV-2 induces the breakdown of immune tolerance. The frequency of autoimmune CNS disorders was evaluated in a prospective cohort with patients admitted to the COVID-19 Intense Care Unity (ICU) in Rio de Janeiro. Then, an in silico analysis was performed to identify the conserved regions that share a high identity between SARS-CoV-2 antigens and human proteins. The sequences with significant identity and antigenic properties were then assessed for their binding capacity to HLA subtypes. Of the 112 patients included, 3 were classified as having an autoimmune disorder. A total of eleven combinations had significant linear and three-dimensional overlap. NMDAR1, MOG, and MPO were the self-antigens with more significant combinations, followed by GAD65. All sequences presented at least one epitope with strong or intermediate binding capacity to the HLA subtypes selected. This study underscores the possibility that CNS autoimmune attacks observed in COVID-19 patients, including those in our population, could be driven by MM in genetically predisposed individuals.

17 March 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
SASoniza Vieira Alves-Leon
Soniza Vieira Alves-Leon
CFCristina dos Santos Ferreira
Cristina dos Santos Ferreira
AHAlice Laschuk Herlinger
Alice Laschuk Herlinger
FFFabricia Lima Fontes-Dantas
Fabricia Lima Fontes-Dantas
FRFernanda Cristina Rueda-Lopes
Fernanda Cristina Rueda-Lopes
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
Chikungunya virus (CHIKV) is a re-emergent arbovirus that causes a disease characterized primarily by fever, rash and severe persistent polyarthralgia, although <1% of cases develop severe neurological manifestations such as inflammatory demyelinating diseases (IDD) of the central nervous system (CNS) like acute disseminated encephalomyelitis (ADEM) and extensive transverse myelitis. Genetic factors associated with host response and disease severity are still poorly understood. In this study, we performed whole-exome sequencing (WES) to identify HLA alleles, genes and cellular pathways associated with CNS IDD clinical phenotype outcomes following CHIKV infection. The cohort includes 345 patients of which 160 were confirmed for CHIKV. Six cases presented neurological manifestation mimetizing CNS IDD. WES data analysis was performed for 12 patients, including the CNS IDD cases and 6 CHIKV patients without any neurological manifestation. We identified 29 candidate genes harboring rare, pathogenic, or probably pathogenic variants in all exomes analyzed. HLA alleles were also determined and patients who developed CNS IDD shared a common signature with diseases such as Multiple sclerosis (MS) and Neuromyelitis Optica Spectrum Disorders (NMOSD). When these genes were included in Gene Ontology analyses, pathways associated with CNS IDD syndromes were retrieved, suggesting that CHIKV-induced CNS outcomesmay share a genetic background with other neurological disorders. To our knowledge, this study was the first genome-wide investigation of genetic risk factors for CNS phenotypes in CHIKV infection. Our data suggest that HLA-DRB1 alleles associated with demyelinating diseases may also confer risk of CNS IDD outcomes in patients with CHIKV infection.

2 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
EGElisa Gouvea Gutman
Elisa Gouvea Gutman
RFRenan Amphilophio Fernandes
Renan Amphilophio Fernandes
JRJéssica Vasques Raposo-Vedovi
Jéssica Vasques Raposo-Vedovi
ASAndreza Salvio Lemos Salvio
Andreza Salvio Lemos Salvio
LDLarissa Araujo Duarte
Larissa Araujo Duarte
SASoniza Vieira Alves-Leon
Soniza Vieira Alves-Leon
SARS-CoV-2 can trigger autoimmune central nervous system (CNS) diseases in genetically susceptible individuals, a mechanism poorly understood. Molecular mimicry (MM) has been identified in other viral diseases as potential triggers of autoimmune CNS events. This study investigated if MM is the process through which SARS-CoV-2 induce the breakdown of immune tolerance. The frequency of autoimmune CNS disorders was evaluated in a prospective cohort with patients admitted in the COVID-19 Intense Care Unity (ICU) in Rio de Janeiro. Then, an in silico analysis was performed to identify the conserved regions which share high identity between SARS-Cov-2 anti-gens and human proteins. The sequences with significant identity and antigenic properties were then assessed for their binding capacity to HLA subtypes. Of the 112 patients included, 3 were classified as having an autoimmune disorder. A total of eleven combinations had significant linear and three-dimensional overlap. NMDAR1, MOG and MPO were the self-antigens with more significant combinations, followed by GAD65. All sequences presented at least one epitope with strong or intermediate binding capacity to the HLA subtypes selected. This study underscores the possibility that CNS autoimmune attacks observed in COVID-19 patients, including those in our population, could be driven by MM in genetically predisposed individuals.

4 February 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
VEVictor Rodrigues Pereira Evangelista
Victor Rodrigues Pereira Evangelista
SMSofia Abreu Mermelstein
Sofia Abreu Mermelstein
MSMarcos Da Silva
Marcos Da Silva
Diego KaskiDiego Kaski
Diego Kaski